BeiGene (BGNE)
(Real Time Quote from BATS)
$199.32 USD
+2.04 (1.03%)
Updated Sep 19, 2024 01:06 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for BeiGene, Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -881.71 | -2,003.82 | -1,413.35 | -1,600.52 | -950.58 |
Depreciation/Amortization & Depletion | 87.68 | 66.28 | 46.46 | -82.20 | 18.62 |
Net Change from Assets/Liabilities | -370.54 | 132.39 | -118.35 | 150.58 | -10.83 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.12 | 308.53 | 186.52 | 248.68 | 192.53 |
Net Cash From Operating Activities | -1,157.45 | -1,496.62 | -1,298.72 | -1,283.46 | -750.27 |
Property & Equipment | -561.90 | -325.43 | -262.94 | -117.51 | -89.61 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 656.27 | 1,546.22 | 3,103.39 | -2,939.33 | 712.77 |
Other Investing Activities | -34.37 | -143.67 | -51.91 | -111.53 | -69.00 |
Net Cash from Investing Activities | 60.00 | 1,077.12 | 640.66 | -3,168.37 | 554.16 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 55.71 | 46.96 | 142.76 | 4,325.12 | 47.00 |
Issuance (Repayment) of Debt | 8.81 | 37.37 | 16.84 | 0.00 | 34.68 |
Increase (Decrease) Short-Term Debt | 351.95 | -103.31 | 84.70 | 289.60 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 3,392.62 | 588.11 | 4.00 |
Net Cash from Financing Activities | 416.48 | -18.97 | 3,636.91 | 5,202.83 | 85.68 |
Effect of Exchange Rate Changes | -8.08 | -69.38 | 14.04 | 18.23 | -9.51 |
Net Change In Cash & Equivalents | -689.05 | -507.85 | 2,992.88 | 769.23 | -119.94 |
Cash at Beginning of Period | 3,875.04 | 4,382.89 | 1,390.01 | 620.78 | 740.71 |
Cash at End of Period | 3,185.98 | 3,875.04 | 4,382.89 | 1,390.01 | 620.78 |
Diluted Net EPS | -8.45 | -19.43 | -15.23 | -19.13 | -15.80 |
Fiscal Year End for BeiGene, Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -371.56 | -251.15 | -881.71 | -514.16 | -729.57 |
Depreciation/Amortization & Depletion | 50.22 | 25.29 | 87.68 | 63.86 | 42.35 |
Net Change from Assets/Liabilities | -268.77 | -155.36 | -370.54 | -387.56 | -329.40 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 185.94 | 72.64 | 7.12 | -97.96 | 158.95 |
Net Cash From Operating Activities | -404.16 | -308.57 | -1,157.45 | -935.82 | -857.67 |
Property & Equipment | -266.53 | -156.58 | -561.90 | -404.94 | -247.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 2.66 | 2.66 | 656.27 | 551.94 | 555.92 |
Other Investing Activities | -56.99 | -55.91 | -34.37 | -24.41 | 0.00 |
Net Cash from Investing Activities | -320.86 | -209.83 | 60.00 | 122.59 | 308.86 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 20.36 | 14.79 | 55.71 | 52.35 | 35.17 |
Issuance (Repayment) of Debt | -4.97 | 5.47 | 8.81 | 14.04 | 15.77 |
Increase (Decrease) Short-Term Debt | 166.92 | 142.03 | 351.95 | 3.04 | 95.27 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 185.31 | 162.29 | 416.48 | 69.43 | 146.21 |
Effect of Exchange Rate Changes | -28.34 | -22.44 | -8.08 | -50.35 | -50.87 |
Net Change In Cash & Equivalents | -568.05 | -378.55 | -689.05 | -794.15 | -453.46 |
Cash at Beginning of Period | 3,185.98 | 3,185.98 | 3,875.04 | 3,875.04 | 3,875.04 |
Cash at End of Period | 2,617.93 | 2,807.44 | 3,185.98 | 3,080.89 | 3,421.57 |
Diluted Net EPS | -1.15 | -2.41 | -3.48 | 2.01 | -3.64 |